Logo image of TRZ.CA

TRANSAT A.T. INC (TRZ.CA) Stock Fundamental Analysis

TSX:TRZ - Toronto Stock Exchange - CA89351T4019 - Common Stock - Currency: CAD

2.82  -0.06 (-2.08%)

Fundamental Rating

2

TRZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 9 industry peers in the Passenger Airlines industry. TRZ has a bad profitability rating. Also its financial health evaluation is rather negative. TRZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

TRZ had negative earnings in the past year.
In the past year TRZ had a positive cash flow from operations.
In the past 5 years TRZ always reported negative net income.
In multiple years TRZ reported negative operating cash flow during the last 5 years.
TRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFTRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of TRZ (-5.09%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.72%, TRZ is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
ROA -5.09%
ROE N/A
ROIC 2.72%
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRZ.CA Yearly ROA, ROE, ROICTRZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

With a Operating Margin value of 1.34%, TRZ is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Looking at the Gross Margin, with a value of 49.13%, TRZ is in line with its industry, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Gross Margin of TRZ has remained more or less at the same level.
Industry RankSector Rank
OM 1.34%
PM (TTM) N/A
GM 49.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
TRZ.CA Yearly Profit, Operating, Gross MarginsTRZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRZ is destroying value.
Compared to 1 year ago, TRZ has more shares outstanding
The number of shares outstanding for TRZ has been increased compared to 5 years ago.
TRZ has a worse debt/assets ratio than last year.
TRZ.CA Yearly Shares OutstandingTRZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
TRZ.CA Yearly Total Debt VS Total AssetsTRZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.48, we must say that TRZ is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.48, TRZ is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
TRZ has a debt to FCF ratio of 26.00. This is a negative value and a sign of low solvency as TRZ would need 26.00 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 26.00, TRZ is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 26
Altman-Z 0.48
ROIC/WACC0.7
WACC3.89%
TRZ.CA Yearly LT Debt VS Equity VS FCFTRZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.76 indicates that TRZ may have some problems paying its short term obligations.
With a Current ratio value of 0.76, TRZ is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Quick Ratio of 0.74 indicates that TRZ may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.74, TRZ is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.74
TRZ.CA Yearly Current Assets VS Current LiabilitesTRZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for TRZ have decreased strongly by -36.42% in the last year.
The Revenue has been growing slightly by 3.55% in the past year.
TRZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.26% yearly.
EPS 1Y (TTM)-36.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.76%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%5.95%

3.2 Future

TRZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.21% yearly.
The Revenue is expected to grow by 4.74% on average over the next years.
EPS Next Y10.7%
EPS Next 2Y20.73%
EPS Next 3Y24.21%
EPS Next 5YN/A
Revenue Next Year5.3%
Revenue Next 2Y4.71%
Revenue Next 3Y4.74%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRZ.CA Yearly Revenue VS EstimatesTRZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TRZ.CA Yearly EPS VS EstimatesTRZ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRZ. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TRZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRZ.CA Price Earnings VS Forward Price EarningsTRZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TRZ indicates a somewhat cheap valuation: TRZ is cheaper than 77.78% of the companies listed in the same industry.
TRZ's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TRZ is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.41
EV/EBITDA 5.75
TRZ.CA Per share dataTRZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as TRZ's earnings are expected to grow with 24.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.73%
EPS Next 3Y24.21%

0

5. Dividend

5.1 Amount

No dividends for TRZ!.
Industry RankSector Rank
Dividend Yield N/A

TRANSAT A.T. INC

TSX:TRZ (7/11/2025, 7:00:00 PM)

2.82

-0.06 (-2.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)06-10 2025-06-10/amc
Earnings (Next)09-10 2025-09-10/amc
Inst Owners26.26%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap112.77M
Analysts47.27
Price Target3.11 (10.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.22%
Min EPS beat(2)9.56%
Max EPS beat(2)112.88%
EPS beat(4)3
Avg EPS beat(4)79.93%
Min EPS beat(4)-93.62%
Max EPS beat(4)290.9%
EPS beat(8)5
Avg EPS beat(8)226.17%
EPS beat(12)8
Avg EPS beat(12)159.39%
EPS beat(16)8
Avg EPS beat(16)115.22%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-0.38%
Max Revenue beat(2)1.08%
Revenue beat(4)2
Avg Revenue beat(4)0.21%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)3.03%
Revenue beat(8)5
Avg Revenue beat(8)0.33%
Revenue beat(12)6
Avg Revenue beat(12)-0.66%
Revenue beat(16)7
Avg Revenue beat(16)-1.81%
PT rev (1m)90.63%
PT rev (3m)98.05%
EPS NQ rev (1m)55.69%
EPS NQ rev (3m)55.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.25%
Revenue NQ rev (3m)-1.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 1.41
P/OCF 0.64
P/B N/A
P/tB N/A
EV/EBITDA 5.75
EPS(TTM)-2.21
EYN/A
EPS(NY)-1.93
Fwd EYN/A
FCF(TTM)2
FCFY70.77%
OCF(TTM)4.43
OCFY157.11%
SpS84.66
BVpS-25.85
TBVpS-26.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.09%
ROE N/A
ROCE 3.78%
ROIC 2.72%
ROICexc 4.89%
ROICexgc 4.99%
OM 1.34%
PM (TTM) N/A
GM 49.13%
FCFM 2.36%
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
F-Score2
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 26
Debt/EBITDA 6.66
Cap/Depr 40.14%
Cap/Sales 2.88%
Interest Coverage 0.41
Cash Conversion 61.51%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.74
Altman-Z 0.48
F-Score2
WACC3.89%
ROIC/WACC0.7
Cap/Depr(3y)38.18%
Cap/Depr(5y)29.63%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.76%
EPS Next Y10.7%
EPS Next 2Y20.73%
EPS Next 3Y24.21%
EPS Next 5YN/A
Revenue 1Y (TTM)3.55%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%5.95%
Revenue Next Year5.3%
Revenue Next 2Y4.71%
Revenue Next 3Y4.74%
Revenue Next 5YN/A
EBIT growth 1Y15.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year503.88%
EBIT Next 3Y102.67%
EBIT Next 5YN/A
FCF growth 1Y-64.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.6%
OCF growth 3YN/A
OCF growth 5Y-15.21%